177 related articles for article (PubMed ID: 11756447)
21. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
Wei Y; Eble JA; Wang Z; Kreidberg JA; Chapman HA
Mol Biol Cell; 2001 Oct; 12(10):2975-86. PubMed ID: 11598185
[TBL] [Abstract][Full Text] [Related]
22. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
Kiyan J; Haller H; Dumler I
Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the uPAR/uPA system expressed on monocytes by the deactivating cytokines, IL-4, IL-10 and IL-13: consequences on cell adhesion to vitronectin and fibrinogen.
Paysant J; Vasse M; Soria J; Lenormand B; Pourtau J; Vannier JP; Soria C
Br J Haematol; 1998 Jan; 100(1):45-51. PubMed ID: 9450789
[TBL] [Abstract][Full Text] [Related]
24. alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells.
Rusnati M; Tanghetti E; Dell'Era P; Gualandris A; Presta M
Mol Biol Cell; 1997 Dec; 8(12):2449-61. PubMed ID: 9398667
[TBL] [Abstract][Full Text] [Related]
25. Urokinase/urokinase receptor and vitronectin/alpha(v)beta(3) integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways.
Degryse B; Orlando S; Resnati M; Rabbani SA; Blasi F
Oncogene; 2001 Apr; 20(16):2032-43. PubMed ID: 11360187
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of zinc-dependent leukocyte adhesion involving the urokinase receptor and beta2-integrins.
Chavakis T; May AE; Preissner KT; Kanse SM
Blood; 1999 May; 93(9):2976-83. PubMed ID: 10216093
[TBL] [Abstract][Full Text] [Related]
27. Different mechanisms define the antiadhesive function of high molecular weight kininogen in integrin- and urokinase receptor-dependent interactions.
Chavakis T; Kanse SM; Lupu F; Hammes HP; Müller-Esterl W; Pixley RA; Colman RW; Preissner KT
Blood; 2000 Jul; 96(2):514-22. PubMed ID: 10887113
[TBL] [Abstract][Full Text] [Related]
28. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading.
Planus E; Barlovatz-Meimon G; Rogers RA; Bonavaud S; Ingber DE; Wang N
J Cell Sci; 1997 May; 110 ( Pt 9)():1091-8. PubMed ID: 9175705
[TBL] [Abstract][Full Text] [Related]
29. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
Deng G; Curriden SA; Wang S; Rosenberg S; Loskutoff DJ
J Cell Biol; 1996 Sep; 134(6):1563-71. PubMed ID: 8830783
[TBL] [Abstract][Full Text] [Related]
30. Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer.
Carriero MV; Del Vecchio S; Capozzoli M; Franco P; Fontana L; Zannetti A; Botti G; D'Aiuto G; Salvatore M; Stoppelli MP
Cancer Res; 1999 Oct; 59(20):5307-14. PubMed ID: 10537314
[TBL] [Abstract][Full Text] [Related]
31. Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction.
Kusch A; Tkachuk S; Haller H; Dietz R; Gulba DC; Lipp M; Dumler I
J Biol Chem; 2000 Dec; 275(50):39466-73. PubMed ID: 10995743
[TBL] [Abstract][Full Text] [Related]
32. Potential role for insulin-like growth factor II and vitronectin in the endothelial-mesenchymal transition process.
Arciniegas E; Neves YC; Carrillo LM
Differentiation; 2006 Jul; 74(6):277-92. PubMed ID: 16831197
[TBL] [Abstract][Full Text] [Related]
33. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells.
Dumler I; Weis A; Mayboroda OA; Maasch C; Jerke U; Haller H; Gulba DC
J Biol Chem; 1998 Jan; 273(1):315-21. PubMed ID: 9417082
[TBL] [Abstract][Full Text] [Related]
34. Vitronectin binding to urokinase receptor in human breast cancer.
Carriero MV; Del Vecchio S; Franco P; Potena MI; Chiaradonna F; Botti G; Stoppelli MP; Salvatore M
Clin Cancer Res; 1997 Aug; 3(8):1299-308. PubMed ID: 9815812
[TBL] [Abstract][Full Text] [Related]
35. Urokinase links plasminogen activation and cell adhesion by cleavage of the RGD motif in vitronectin.
De Lorenzi V; Sarra Ferraris GM; Madsen JB; Lupia M; Andreasen PA; Sidenius N
EMBO Rep; 2016 Jul; 17(7):982-98. PubMed ID: 27189837
[TBL] [Abstract][Full Text] [Related]
36. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
Whitley BR; Church FC
Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
[TBL] [Abstract][Full Text] [Related]
37. Urokinase regulates vitronectin binding by controlling urokinase receptor oligomerization.
Sidenius N; Andolfo A; Fesce R; Blasi F
J Biol Chem; 2002 Aug; 277(31):27982-90. PubMed ID: 12034711
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility.
Franco P; Iaccarino C; Chiaradonna F; Brandazza A; Iavarone C; Mastronicola MR; Nolli ML; Stoppelli MP
J Cell Biol; 1997 May; 137(3):779-91. PubMed ID: 9151681
[TBL] [Abstract][Full Text] [Related]
39. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
[TBL] [Abstract][Full Text] [Related]
40. UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1.
Lugano R; Peña E; Casani L; Badimon L; Padró T
Cardiovasc Res; 2013 Nov; 100(2):262-71. PubMed ID: 23812296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
